Cysteamine – finalist of the Medical Aesthetic Innovation Awards @ IMCAS World Congress 2018

IMCAS Medical Aesthetics Innovation Forum

Everyday innovators are looking for opportunities to bring exciting new products and devices to market, and venture capitalists and CEOs are looking to invest in cutting-edge innovations.

For the first time, IMCAS, in collaboration with the Dermatology Summit and the Masters of Aesthetics, is hosting the Aesthetics Innovation Forum to gather these key international leaders, who are excited about developing aesthetic science ideas into products which can substantially improve skin health and appearance.

The forum focuses on educating participants about inspiring innovations that can provide the basis for the generation of a mutually beneficial relationships among investors, strategic corporate partners, service providers, government regulators, patient advocates, and other stakeholders.

A shark tank session will welcome selected start-ups to present the innovations of tomorrow. An award will be provided to the most convincing pitch.

This forum also provides a unique networking venue for its attendees to communicate with, learn from and collaborate with leaders that have brought game- changing products from concept to market.

Chair:

ASCHER Benjamin, Plastic surgeon, France

Coordinators

AVRAM Mathew, Dermatologist United States

BRONES Laurent, Business development manager, Symatese, France

ORTIZ Arisa, Dermatologist, United States

DU CREST Dominique, SkinAid Founder, France

Advisors

JU William, Dermatologist, United States

MORDON Serge, PhD - Research, France

 

Presenting the Innovations of Tomorrow

 

Discover Cysteamine at IMCAS World Congress 2018

Cysteamine @ IMCAS World Congress

Cysteamine is finalist of the IMCAS Innovation Awards

Cysteamine is presented at the New Tech Conference